Immunological Reviews

Immunological Reviews is a peer-reviewed review journal published by Wiley, founded in 1977 as the continuation of Transplantation Reviews, which the Copenhagen publisher Munksgaard had issued from 1969 to 1976, in which every volume is devoted to a single topic of immunological research and the volumes together provide a broad and continuously updated survey of advances in basic immunology and their clinical applications, and which carries a 2025 Journal Impact Factor of 10.6 and a first-quartile ranking in the Journal Citation Reports category IMMUNOLOGY《免疫学评论》（Immunological Reviews）是（Wiley）出版的同行评审综述期刊，1977 年创刊，延续哥本哈根（Munksgaard）1969 年至 1976 年间出版的《移植评论》（Transplantation Reviews），每卷围绕单一免疫学主题，各卷合起来提供基础免疫学进展及其临床应用的广泛而持续更新的综述，2025 年影响因子为 10.6，居期刊引用报告（JCR）免疫学（IMMUNOLOGY）学科 Q1 区。

Scope

• The stated aim of the journal is that, while each volume is devoted to a single topic of immunological research, the volumes collectively provide a broad and continuously updated survey of advances in basic immunology and their clinical applications该刊的既定宗旨是每一卷围绕单一免疫学研究主题，而各卷合起来提供基础免疫学进展及其临床应用的广泛且持续更新的综述。
• It publishes only invited reviews, each accompanied by an introduction article written by the guest editors of the volume, and it does not accept unsolicited manuscripts该刊仅发表邀约综述，每篇附该卷客座编辑撰写的引言文章，不接受未经邀约的稿件。
• Selected topics represent fields in which knowledge or understanding is expanding, areas in which previously separated lines of investigation are being synthesized, and subjects in which previously held views are challenged by more recent findings所选主题既包括知识或认识不断拓展的领域、此前分散的研究路线被综合的领域，也包括既有观点受到新近发现挑战的课题。
• Invited reviews run 10,000 to 14,000 words, roughly 45 double-spaced manuscript pages, and are submitted in free format with a 200-word abstract and three to six keywords邀约综述篇幅为 10000 至 14000 词，约合 45 个双倍行距手稿页，以自由格式投稿，附 200 词摘要与 3 至 6 个关键词。
• Authors may publish under the standard copyright agreement of the journal or choose open access under a Creative Commons license for a fee, so the journal follows a hybrid open access model作者可选择该刊的标准版权协议发表，也可付费依照知识共享（Creative Commons）许可开放获取发表，故该刊采用混合开放获取模式。
• Articles appear by continuous publication as soon as they are ready, without waiting for a whole issue to be assembled, and proofs must be returned within 48 hours论文以连续出版方式上线，无需等待整期汇编，校样须在 48 小时内返还。
• The journal is a member of the Committee on Publication Ethics, screens submitted text with iThenticate similarity checking, and requires an ORCID iD from every submitting author该刊为国际出版伦理委员会（COPE）成员期刊，投稿文本经（iThenticate）相似性检测，并要求每位投稿作者提供（ORCID）标识。
• It is indexed in MEDLINE and PubMed, with coverage running from volume 33 of January 1977, and in the Science Citation Index Expanded该刊被（MEDLINE）与（PubMed）收录，收录自 1977 年 1 月第 33 卷起，并收录于科学引文索引扩展版（SCIE）。

History

• The journal grew out of Transplantation Reviews, published in Copenhagen by Munksgaard from 1969 to 1976 in 32 volumes, and Immunological Reviews continued the numbering from volume 33 in January 1977该刊由哥本哈根（Munksgaard）于 1969 年至 1976 年间出版 32 卷的《移植评论》（Transplantation Reviews）发展而来，《免疫学评论》自 1977 年 1 月第 33 卷起延续其卷号。
• The Swedish immunologist Goran Moller served as founding editor from volume 33, and the journal was issued by Munksgaard in Copenhagen until 2008, by Blackwell Publishing in 2008 and by Wiley from 2009瑞典免疫学家（Goran Moller）自第 33 卷起任创刊主编，该刊在哥本哈根由（Munksgaard）出版至 2008 年，2008 年改由（Blackwell Publishing）出版，2009 年起归入（Wiley）。
• Every volume is devoted to one immunological topic and is published complete in a single issue, a format that has defined the journal since its earliest years该刊每卷聚焦一个免疫学主题并以单期完整出版，这一体例自创刊初期延续至今。
• The journal has been bimonthly since August 1984, and since 2022 it appears eight times a year, in January, March, May, July, August, September, October and November该刊自 1984 年 8 月起按双月刊出版，2022 年起每年出版 8 期，即 1 月、3 月、5 月、7 月、8 月、9 月、10 月与 11 月。
• Its Journal Impact Factor has moved around ten in recent years, recorded as 12.988 for 2021, 10.983 for 2022, 8.3 for 2024 and 10.6 for 2025, when it ranked 17th among the 183 journals of the JCR category IMMUNOLOGY其影响因子近年围绕 10 波动，2021 年为 12.988，2022 年为 10.983，2024 年为 8.3，2025 年为 10.6，当年在该学科 183 种期刊中位列第 17。
• Volume 343, issue 1 appeared in October 2026, and the backfile on the publisher platform holds more than 5000 items, with over 520,000 citations recorded in OpenAlex该刊 2026 年 10 月已出版至第 343 卷第 1 期，出版方平台回溯档案收录逾 5000 篇文献，（OpenAlex）记录其被引超过 52 万次。

Editors

• John Cambier, Distinguished Professor and emeritus chair of the Department of Immunology and Microbiology at the University of Colorado Anschutz School of Medicine in Denver, is the editor-in-chief（John Cambier）任主编，为美国科罗拉多大学安舒茨医学院免疫学与微生物学系杰出教授、荣休系主任。
• His research centers on intracellular signaling in cells of the immune system, in particular inhibitory receptors and feedback regulatory circuits in adaptive and innate immunity其研究聚焦免疫细胞的胞内信号转导，尤其是抑制性受体及适应性免疫与固有免疫中的反馈调控环路。
• The founding editor was the Swedish immunologist Goran Moller, and an editorial office administered by Wiley runs the journal创刊主编为瑞典免疫学家（Goran Moller），期刊日常运营由（Wiley）管理的编辑部负责。
• The editorial board numbers thirty members, among them Rafi Ahmed of Atlanta, Chen Dong and Hai Qi of Tsinghua University, Alain Fischer of Paris, Tomohiro Kurosaki of Kanagawa, Shimon Sakaguchi of Kyoto, Michael Reth of Freiburg, Ann O'Garra of London, David Tarlinton of Monash University and Arthur Weiss of San Francisco编委会由 30 位委员组成，包括亚特兰大的（Rafi Ahmed）、清华大学的（Chen Dong）与（Hai Qi）、巴黎的（Alain Fischer）、神奈川的（Tomohiro Kurosaki）、京都的（Shimon Sakaguchi）、弗赖堡的（Michael Reth）、伦敦的（Ann O'Garra）、莫纳什大学的（David Tarlinton）与旧金山的（Arthur Weiss）。
• Members are based in the United States, China, France, Italy, the United Kingdom, Germany, Japan, Australia, Canada, Mexico and Portugal, giving the board a broad international composition委员分布于美国、中国、法国、意大利、英国、德国、日本、澳大利亚、加拿大、墨西哥与葡萄牙，编委会的国际构成广泛。
• Contributions are commissioned by the editorial board and each volume is guest-edited with an introduction, so there is no route for unsolicited submissions and no pre-submission enquiry stage, and manuscripts enter through the Wiley Research Exchange portal稿件由编委会邀约，每卷设客座编辑并撰写引言，既无自由投稿通道，也不设投稿前咨询环节，稿件经（Wiley Research Exchange）门户提交。